CPHI vs TMO · rev $4.1M vs P/E 24, rev $44.56B
China Pharma Holdings Inc (CPHI) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CPHI currently screens at market cap $29.0M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CPHI and TMO stock pages for the full models.
Not investment advice.